The data from our study highlight the importance of IL4I1 and IDO1 expression in HNSCC and suggest a potential interplay between these enzymes, which is especially important since it was suggested that IL4I1 may be the reason for the prior failure of clinical studies combining immunotherapy with IDO1 inhibition [17]. Here, IDO1 is linked to head and neck squamous cell carcinoma.